Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1DP6 is annotated as a **pseudogene** of the EEF1D gene, which encodes the elongation factor 1-delta (EEF1D)—a guanine nucleotide exchange factor that is part of the eukaryotic elongation factor 1 (eEF1) complex required for protein synthesis in eukaryotic cells. The EEF1DP6 locus does not encode a functional protein and is not known to have any established role in translation, cellular regulation, or disease. There is no evidence that EEF1DP6 is a therapeutic target, biomarker, or subject of any current drug development. Its status as a pseudogene means it does not participate in canonical molecular or cellular processes[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 delta pseudogene 6 (EEF1DP6).